Convertibles Calendar: BlackLine, Clovis Oncology on tap

Aug. 8

BLACKLINE INC.:

• $435 million five-year convertible notes

• Coupon of 0% to 0.5% and initial conversion premium of 32.5% to 37.5%

• Greenshoe of $65 million

• Non-callable for three years and then subject to a 130% hurdle

• Rule 144A

• J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC

• Proceeds to cover cost of the spread and for general corporate purposes

• Los Angeles-based cloud-based accounting and finance software company

CLOVIS ONCOLOGY INC.:

• $225 million five-year convertible notes

• Coupon of 4% to 4.5% and an initial conversion premium of 25% to 30%

• Greenshoe of $33.75 million

• Non-callable

• Rule 144A

• J.P. Morgan Securities LLC and BofA Securities Inc.

• Proceeds to repurchase a portion of Clovis’ 2.5% convertible notes due 2021 and for general corporate purposes

• Boulder, Colo.-based biopharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.